Denosumab improves disease-free survival for postmenopausal HR-positive breast cancer
Denosumab improves disease-free survival for postmenopausal HR-positive breast cancer
Pathologic complete response to presurgery chemo improves survival for triple-negative breast cancer
Cancer Core Europe: where did it come from and what is its future?
Mouse tumour models in the EurocanPlatform project
The POSEIDON trial of the EurocanPlatform project
Highlights of the EurocanPlatform Project
Cancer Core Europe: what has been achieved one year on?
Cancer Core Europe: one year on (full version)
Large B-cell non-Hodgkin’s lymphoma: Optimising therapy for elderly patients
Geonomic testing may help predict metastatic risk after prostatectomy and salvage radiotherapy
Longer duration of ADT after radiotherapy improves disease-free survival in prostate cancer
ECC 2015 scientific highlights